Pet Health was Elanco Animal Health’s largest product and service line in fiscal 2025, bringing in $2.30B of $4.72B (49%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pet Health | $2.14B | $2.10B | $2.14B | $2.30B | ||||||
| Farm Animal | — | — | — | — | ||||||
| Food Animal Ruminants Swine | — | — | — | — | ||||||
| Farm Animal Ruminants & Swine | — | — | — | — | ||||||
| Cattle | $944.00M | $949.00M | $1.01B | $1.13B | ||||||
| Pet Health Disease Prevention | — | — | — | — | ||||||
| Poultry | $716.00M | $765.00M | $796.00M | $858.00M | ||||||
| Farm Animal Future Protein & Health | — | — | — | — | ||||||
| Companion Animal Disease Prevention | — | — | — | — | ||||||
| Food Animal Future Protein & Health | — | — | — | — | ||||||
| Swine | $384.00M | $382.00M | $366.00M | $379.00M | ||||||
| Pet Health Therapeutics | — | — | — | — | ||||||
| Companion Animal Therapeutics | — | — | — | — | ||||||
| Aqua | $175.00M | $175.00M | $81.00M | — | ||||||
| Companion Animal Other | — | — | — | — | ||||||
| Contract Manufacturing & Other | — | $42.00M | $46.00M | $53.00M | ||||||
| Contract Manufacturing | $54.00M | — | — | — | ||||||
| Strategic Exits | — | — | — | — | ||||||
| Total | $4.41B | $4.42B | $4.44B | $4.72B |
Elanco Animal Health brought in $4.72B from its five product and service lines in fiscal 2025, the year ended December 31, 2025. Elanco Animal Health regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $4.44B. Pet Health was the largest at $2.30B (48.8%), ahead of Cattle at $1.13B (23.9%) and Poultry at $858.00M (18.2%). The other two lines brought in $432.00M combined.
Compared with fiscal 2024, Cattle grew fastest, up 11.7% to $1.13B. Every line above 2% of revenue grew.
Elanco Animal Health began breaking out Contract Manufacturing & Other in fiscal 2023, when it brought in $42.00M. Elanco Animal Health stopped reporting Aqua ($81.00M in fiscal 2024) and Contract Manufacturing ($54.00M in fiscal 2022) as separate lines.
International was Elanco Animal Health’s largest region in fiscal 2025, bringing in $2.48B of $4.72B (53%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| International | $2.45B | $2.43B | $2.40B | $2.48B | ||||||
| Non-Us | — | — | — | — | ||||||
| Next Largest Country | — | — | — | — | ||||||
| United States | $1.97B | $1.98B | $2.04B | $2.23B | ||||||
| Total | $4.41B | $4.42B | $4.44B | $4.72B |
Elanco Animal Health brought in $4.72B from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 6.2% from $4.44B in fiscal 2024. International was the largest at $2.48B (52.6%), ahead of United States at $2.23B (47.4%).
Compared with fiscal 2024, United States grew 9.7% to $2.23B and International grew 3.2% to $2.48B. From fiscal 2022 to 2025, combined revenue from these regions grew from $4.41B to $4.72B, a compound annual growth rate of 2.2%. International's share of the total fell from 55.5% to 52.6%.
As Reported was Elanco Animal Health’s largest revenue line in fiscal 2021, bringing in $4.77B of $4.76B (100%).
| Revision of Prior Period | FY 2020 | FY 2021 |
|---|---|---|
| As Reported | $3.27B | $4.77B |
| Revisions | -$2.00M | -$1.00M |
| Total | $3.27B | $4.76B |
Elanco Animal Health brought in $4.76B from its two revenue lines in fiscal 2021, the year ended December 31, 2021. That was up 45.6% from $3.27B in fiscal 2020. As Reported was the largest at $4.77B (100.0%).
The total is net of Revisions, which took $1.00M off revenue in fiscal 2021.
Elanco Animal Health (ELAN) reports its revenue by product and service, by geography and by revision of prior period. In fiscal 2025, Pet Health was its largest product and service line, bringing in $2.30B (48.8% of the total), followed by Cattle at $1.13B (23.9%).
Pet Health was Elanco Animal Health's largest product and service line in fiscal 2025, bringing in $2.30B, or 48.8% of the $4.72B total across its five product and service lines.
International was Elanco Animal Health's largest region in fiscal 2025, bringing in $2.48B, or 52.6% of the $4.72B total across its two regions.
As Reported was Elanco Animal Health's largest revenue line in fiscal 2021, bringing in $4.77B, or 100.0% of the $4.76B total across its two revenue lines.
United States grew faster than International in fiscal 2025, up 9.7% from $2.04B to $2.23B. International grew 3.2% to $2.48B.
Every figure comes from Elanco Animal Health's annual financial filings, as reported. Each line keeps the name Elanco Animal Health gives it, and years follow its fiscal calendar.
Elanco Animal Health's revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.